CA2126441A1 - Microcrystalline Cellulose Spheronization Composition - Google Patents

Microcrystalline Cellulose Spheronization Composition

Info

Publication number
CA2126441A1
CA2126441A1 CA 2126441 CA2126441A CA2126441A1 CA 2126441 A1 CA2126441 A1 CA 2126441A1 CA 2126441 CA2126441 CA 2126441 CA 2126441 A CA2126441 A CA 2126441A CA 2126441 A1 CA2126441 A1 CA 2126441A1
Authority
CA
Canada
Prior art keywords
composition
microcrystalline cellulose
hydrocolloid
spheronization
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2126441
Other languages
French (fr)
Other versions
CA2126441C (en
Inventor
David F. Erkoboni
Scott A. Fiore
Thomas A. Wheatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2126441A1 publication Critical patent/CA2126441A1/en
Application granted granted Critical
Publication of CA2126441C publication Critical patent/CA2126441C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/005—Processes for mixing polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/14—Water soluble or water swellable polymers, e.g. aqueous gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers

Abstract

A particulate co-processed unattrited microcrystalline cellulose: hydrocolloid composition wherein the respective components are present in a weight ratio of from about 99:1 to 70:30. The composition is useful as a spheronizing agent for producing spheroids of uniform size and sphericity and having high drug loadings. The composition is produced by drying a slurry of the microcrystalline cellulose in an aqueous solution of the hydrocolloid. The preferred hydrocolloid is methyl cellulose.
CA002126441A 1991-12-30 1992-11-18 Microcrystalline cellulose spheronization composition Expired - Fee Related CA2126441C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81602791A 1991-12-30 1991-12-30
US816,027 1991-12-30
PCT/US1992/009983 WO1993012768A1 (en) 1991-12-30 1992-11-18 Microcrystalline cellulose spheronization composition

Publications (2)

Publication Number Publication Date
CA2126441A1 true CA2126441A1 (en) 1993-07-08
CA2126441C CA2126441C (en) 1999-12-21

Family

ID=25219497

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002126441A Expired - Fee Related CA2126441C (en) 1991-12-30 1992-11-18 Microcrystalline cellulose spheronization composition

Country Status (16)

Country Link
US (1) US5725886A (en)
EP (1) EP0619731B1 (en)
JP (1) JP2628230B2 (en)
CN (1) CN1074228A (en)
AT (1) ATE196733T1 (en)
AU (1) AU663146B2 (en)
BR (1) BR9206996A (en)
CA (1) CA2126441C (en)
DE (1) DE69231499T2 (en)
ES (1) ES2150438T3 (en)
FI (1) FI943121A0 (en)
IL (1) IL104087A (en)
MX (1) MX9207438A (en)
NO (1) NO942457L (en)
WO (1) WO1993012768A1 (en)
ZA (1) ZA929161B (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
EA002811B1 (en) * 1996-08-14 2002-10-31 Яманучи Юроп Б.В. Granulantes comprising a water soliable compound and cellulose
CN1086189C (en) * 1997-06-12 2002-06-12 食品机械和化工公司 Ultra-fine microcrystalline cellulose compositions and process for their manufacture
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
DE60035365T2 (en) 1999-09-29 2008-02-28 R.P. Scherer Technologies, Inc., Las Vegas GRANULES OF MEDICINE SALTS WITH HYDROLIZED CELLULOSE
IL151475A0 (en) 2000-03-30 2003-04-10 Bristol Myers Squibb Co Beadlets containing stavudine
HUP0303178A3 (en) * 2001-02-05 2008-03-28 R P Scherer Technologies Methods and compositions for reducing the taste of pharmaceutically active agents
CA2445290A1 (en) * 2001-04-26 2002-11-07 Chenkou Wei A pharmaceutical tablet having a high api content
WO2003096976A2 (en) 2002-05-14 2003-11-27 Fmc Corporation Microcrystalline cewllulose compositions
EA012315B1 (en) * 2005-02-04 2009-08-28 Филип Моррис Продактс С.А. Cigarette and filter with cellulosic flavor addition
US20070000505A1 (en) * 2005-02-24 2007-01-04 Philip Morris Usa Inc. Smoking article with tobacco beads
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
ZA200807571B (en) * 2006-03-01 2009-08-26 Ethypharm Sa Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
NZ574427A (en) * 2006-07-28 2011-11-25 Zaklady Farmaceutyczne Polpharma S A Extended release pharmaceutical formulation of metoprolol and process for its preparation
DE602007011792D1 (en) * 2006-10-27 2011-02-17 Fmc Corp COMMONLY PREPARED MICROCRYSTALLINE CELLULOSE AND SUGAR ALCOHOL AS AN AUXILIARY FOR TABLET FORMULATIONS
EP2144599B1 (en) * 2007-03-02 2010-08-04 Farnam Companies, Inc. Sustained release pellets comprising wax-like material
US9888712B2 (en) 2007-06-08 2018-02-13 Philip Morris Usa Inc. Oral pouch products including a liner and tobacco beads
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
KR101633939B1 (en) * 2007-10-10 2016-06-27 아반토르 퍼포먼스 머티리얼스, 인크. Directly Compressible High Functionality Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
BRPI0921507A2 (en) * 2008-11-19 2016-01-19 Avantor Performance Mat Inc composition, method of preparation of an excipient, pharmaceutical tablet and method of preparation thereof
US9221963B2 (en) 2008-11-27 2015-12-29 Speciality Fibres And Materials Ltd. Absorbent material
US9144625B2 (en) 2008-11-27 2015-09-29 Speciality Fibres And Materials Ltd. Cellulose ethylsulfonate-based absorbent material
US8377215B2 (en) 2008-12-18 2013-02-19 Philip Morris Usa Inc. Moist botanical pouch processing
US8863755B2 (en) * 2009-02-27 2014-10-21 Philip Morris Usa Inc. Controlled flavor release tobacco pouch products and methods of making
US10051884B2 (en) 2010-03-26 2018-08-21 Philip Morris Usa Inc. Controlled release mentholated tobacco beads
US20110277781A1 (en) 2010-03-26 2011-11-17 Philip Morris Usa Inc. Methods for improving quality of mainstream smoke and multicomponent filters and smoking articles therefor
CN103842425B (en) 2011-10-05 2017-05-24 Fmc有限公司 Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
ES2657648T3 (en) 2011-10-05 2018-03-06 Fmc Corporation Stabilizing composition of microcrystalline cellulose and co-reduced carboxymethylcellulose, method for making it and uses
PL2787837T3 (en) 2011-12-09 2017-09-29 Fmc Corporation Co-attrited stabilizer composition
CN105085992B (en) * 2015-09-16 2017-12-29 珠海市东辰医药科技有限公司 A kind of preparation technology of modified microcrystalline cellulose
CN105193738B (en) * 2015-09-21 2018-09-04 珠海市东辰制药有限公司 A kind of preparation process of microcrystalline cellulose pellet
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1010477A (en) * 1962-05-15 1965-11-17 Fmc Corp Method of making cellulose crystallite aggregates in particulate form and product of such method
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4421778A (en) * 1982-11-04 1983-12-20 Rich Products Corporation Freezer stable whipped ice cream and milk shake food products
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Also Published As

Publication number Publication date
WO1993012768A1 (en) 1993-07-08
MX9207438A (en) 1993-06-01
EP0619731A4 (en) 1995-05-03
DE69231499T2 (en) 2001-05-03
BR9206996A (en) 1995-12-05
AU3179393A (en) 1993-07-28
JP2628230B2 (en) 1997-07-09
NO942457D0 (en) 1994-06-29
NO942457L (en) 1994-06-29
EP0619731A1 (en) 1994-10-19
AU663146B2 (en) 1995-09-28
US5725886A (en) 1998-03-10
EP0619731B1 (en) 2000-10-04
IL104087A0 (en) 1993-05-13
ATE196733T1 (en) 2000-10-15
IL104087A (en) 1998-10-30
ZA929161B (en) 1993-05-25
FI943121A (en) 1994-06-29
FI943121A0 (en) 1994-06-29
JPH06511255A (en) 1994-12-15
CN1074228A (en) 1993-07-14
ES2150438T3 (en) 2000-12-01
CA2126441C (en) 1999-12-21
DE69231499D1 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
CA2126441A1 (en) Microcrystalline Cellulose Spheronization Composition
ES8704977A1 (en) Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation.
CA2089430A1 (en) Aqueous pharmaceutical suspension for pharmaceutical active
CA2121435A1 (en) Aqueous pharmaceutical suspension and process for preparation thereof
SE8503092L (en)
ZA877542B (en) Spray dried acetaminophen
CA2194885A1 (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
IE41923L (en) Suspension of xanthan gum
EP0395095A3 (en) Metastable metal colloids and preparation
CA2023815A1 (en) Riboflavin granules containing no inactive ingredient
Lin et al. Effect of Acid Type, Acetic Acid and Sodium Carboxymethyl Cellulose Consentrations on the Formation, Micromeritic, Dissolution and Floating Properties of Theophylline Chitosan Microcapsules
GR3020828T3 (en) Sustained release suppositories and a process for preparation
JPS5455054A (en) Water-despersible compound
JPS5474855A (en) Preparation of finely divided soluble cellulose derivative
JPS57142911A (en) Absorption-improving agent
CA1243956A (en) Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby
US5185336A (en) Method for producing substantially pure vitamin powders
CA2015632A1 (en) Stable solutions of rebeccamycin analog and preparations thereof
CA2105793A1 (en) Process for producing compositions for ruminants
ATE38236T1 (en) STEROID DERIVATIVES.
CA2002552A1 (en) Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine
JPS6468317A (en) Durative preparation
JPS565412A (en) Pharmaceutical composition
RU94031473A (en) COMPOSITION FOR RECEIVING SPHEROIDS, METHOD OF OBTAINING MATERIAL IN THE FORM OF PARTICLES, SOLID DOSED FORM AND METHOD FOR ITS PREPARATION
CA2139399A1 (en) Redispersible Microdenominated Cellulose

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20111118